cfMSC Stem Cell Therapy Targeting COPD

Summary

The primary objectives are to evaluate the safety and efficacy of infusion of fully characterized clonally derived fetal mesenchymal stem cells (cfMSCs) for the control of severe symptoms associated with moderate to severe chronic obstructive pulmonary disease.

Timeline

Start

2026-03-10

Primary completion

2029-03-31

Completion

2030-04-30

Drugs

Indications